Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Haematologica.

Editorial: Haematologica
Fecha: 01/12/1999
Remacha AF, Arrizabalaga B, Villegas A, Manteiga R, Calvo T, Julia A,
Fernandez Fuertes I, Gonzalez FA, Font L, Junca J, del Arco A, Malcorra
JJ, Equiza EP, de Mendiguren BP, Romero M

Deja un comentario